A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the ...
Twenty-six years ago today, on Sept. 17, a teenager who had received an experimental gene therapy died. His death led to needed changes in the clinical trial process while also spurring skepticism ...
The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future of the drug industry. Rocket Pharmaceuticals, a New Jersey-based biotech, ...
The death of a 5-year-old in a hyperbaric chamber in Michigan has prompted calls for more oversight of hyperbaric oxygen therapy in the largely unsupervised wellness industry before another tragedy ...